• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Pernix Therapeutics Holdings Inc

+ Add to Watchlist


7.4700 USD 0.1000 1.32%

As of 20:10:00 ET on 09/19/2014.

Snapshot for Pernix Therapeutics Holdings Inc (PTX)

Open: 7.6200 Day's Range: 7.2500 - 7.8800 Volume: 705,167
Previous Close: 7.5700 52wk Range: 1.6800 - 9.5600 1-Yr Rtn: +172.63%

Stock Chart for PTX

No chart data available.
  • PTX:US 7.4800
  • 1D
  • 1M
  • 1Y
Interactive PTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PTX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3078
Est. EPS (USD) (12/2014) -0.1730
Est. PEG Ratio -
Market Cap (M USD) 284.19
Shares Outstanding (M) 38.04
30 Day Average Volume 461,375
Price/Book (mrq) 2.9181
Price/Sale (ttm) 3.5434
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 09/08/2001
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PTX

Pernix Therapeutics Holdings, Inc. manufactures pharmaceuticals. The Company acquires, develops and markets medications for the pediatric market including treatments for dermatitis, statin-induced ubiquinone deficiency, deficiencies in active cultures due to diet and antibiotics, and upper respiratory conditions.

Douglas Drysdale "Doug"Chairman/President/CEOSanjay S PatelChief Financial Officer
Terence S Novak "Terry"Chief Operating OfficerBrian T DorseySenior VP:Pharmaceutical Dev
More Company Profile & Key Executives for PTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil